[Plasmapheresis treatment in systemic autoimmune disorders]

Area of Science:

• Medical Science
• Immunology
• Therapeutics

Context:

• The historical development of medical treatments often involves repurposing techniques for new applications.
• Plasmapheresis, a therapeutic apheresis technique, has a history in treating various conditions, including autoimmune diseases.
• Establishing the definitive efficacy of established therapies like plasmapheresis necessitates robust scientific validation.

Purpose:

• To critically assess the current standing of plasmapheresis in the treatment of autoimmune illnesses.
• To emphasize the need for evidence-based evaluation of therapeutic methods.
• To highlight the importance of rigorous clinical trials, such as random double-blind tests, in confirming treatment effectiveness.

Summary:

• The efficacy of plasmapheresis in autoimmune diseases requires further validation through random double-blind studies, despite its historical use.
• Anecdotal evidence and accumulated experience are insufficient to establish plasmapheresis as a definitively effective treatment.
• The principle of "heroic medicine" and the cost-benefit ratio are critical considerations in evaluating any therapeutic intervention.

Impact:

• Promotes a shift towards evidence-based medicine and rigorous evaluation of existing and novel therapies.
• Encourages critical appraisal of treatment protocols in autoimmune conditions.
• Underscores the importance of economic factors in healthcare decision-making regarding therapeutic interventions.